Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Antimicrobial Agents and Chemotherapy|June 17, 2009
Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infectionsHolly Kimko, Xu Xu, Partha Nandy, et al.
Frontiers in Pharmacology|November 13, 2024
Modelling hemodynamics regulation in rats and dogs to facilitate drugs safety risk assessmentChristopher J Morris, Michael G Rolf, Linda Starnes, et al.
Elife|December 8, 2023
Homeostasis, injury, and recovery dynamics at multiple scales in a self-organizing mouse intestinal cryptLouis Gall, Carrie Duckworth, Ferran Jardi, et al.
Critical Care (London, England)|November 15, 2012
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumoniaMarin H Kollef, Jean Chastre, Marc Clavel, et al.
Plos Computational Biology|January 14, 2012
A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infectionBambang S Adiwijaya, Tara L Kieffer, Joshua Henshaw, et al.
Frontiers in Systems Biology|August 14, 2025
Coupling quantitative systems pharmacology modelling to machine learning and artificial intelligence for drug development: its pAIns and gAInsNúria Folguera-Blasco, Florencia A T Boshier, Aydar Uatay, et al.
The AAPS Journal|January 11, 2019
What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision DosingThomas M Polasek, Amin Rostami-Hodjegan, Dong-Seok Yim, et al.
Frontiers in Immunology|March 19, 2021
Evaluation of Combination Strategies for the A2AR Inhibitor AZD4635 Across Tumor Microenvironment Conditions via a Systems Pharmacology ModelVeronika Voronova, Kirill Peskov, Yuri Kosinsky, et al.
Annals of Hepatology|May 29, 2016
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis CXavier Forns, Samuel Didier, David Mutimer, et al.
Science Translational Medicine|April 22, 2021
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trialJohn E Le Lay, Qun Du, Minal B Mehta, et al.
Pageof 4